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among those living in rural areas, overall lower median household income for rural dwellers compared to urban dwellers, reduced rates of insurance coverage for rural dwellers, and increased distance to health care services among individuals living in rural communities, one would assume the risk of nonadherence is increased among those living in rural communities. [16] [17] [18] [19] Nearly 50 million individuals are reported to live in rural settings across the United States. 19 Research has continued to show that health-related outcomes are often worse across chronic diseases for individuals living in rural settings. 17, 20 The cause of these poor outcomes is often the center of debate; however, some studies have suggested that access to health care services and medications may contribute. 17, 21, 22 There has been limited research to assess differences in medication adherence in rural and urban communities. 23 As most chronic conditions are currently treated through the use of chronic prescription medications, it is important to evaluate if differences in the use of prescription medications exist between rural and urban populations.
The objective of this study is to compare adherence rates between rural and urban populations. Additionally, the study evaluates differences between known factors that impact adherence among rural and urban populations.
Methods

Database
This study was a retrospective analysis of the 2015 National Consumer Survey on the Medication Experience and Pharmacists' Role. The 2015 National Consumer Survey was conducted using Qualtrics Panels (Qualtrics LLC, Provo, Utah) to provide participant panels and enroll participants based on census statistics for geographic location, age, and gender. Qualtrics Panels is an online sample of study participants maintained by the online survey system, Qualtrics. Participants were recruited online actively by Qualtrics from this sample and results were provided to researchers. All communications to potential participants were delivered electronically. Participation stratification was included to ensure a minimum of 500 respondents from each of the 50 states and the District of Columbia. A total of 26,173 participants completed the study and provided useable data.
Study Population
The study sample included US residents aged 18 years and older at the time of completion. The data were collected in 2015. The sample included all participants from the original data set, but it was limited to those using prescription medications. Data were restricted to include those using between 1 and 30 prescription medications. Additionally, participants with incomplete responses and those reporting living over 200 miles from the nearest pharmacy or living 0 miles from the nearest pharmacy were excluded from the sample.
Variables
Adherence to reported chronic medications was measured based on the 8-item Morisky Medication Adherence Scale (MMAS-8). The scale has been proven to be a reliable and valid measure of patient-reported adherence. [24] [25] [26] The scoring of responses range from 0 (worse possible adherence score) to 8 (best possible adherence score). The scores for participant MMAS-8 were reported both as raw scores ranging from 0 to 8 and grouped by level of adherence, with those scoring less than 6 being defined as low adherers, those scoring 6 to less than 8 defined as medium adherers, and those scoring 8 as high adherers, as recommended. 24 Participant-reported ZIP codes were compared to ruralurban commuting area (RUCA) scores compiled by the Rural Health Research Center to assign each participant's population density as rural, suburban, or urban. RUCA scores classify US Census tracts using measures of population density, urbanization, and daily commuting. The latest version of RUCA scoring, based on 2010 Census data, provides a cross-walk between ZIP codes and RUCA score. Participants residing in a ZIP code with a RUCA score of greater than 6 were defined as rural, those with a RUCA score of between 2 and 6 were defined as suburban, and those with a RUCA score of 1 were defined as urban.
An abbreviated version of the Beliefs about Medicines Questionnaire (BMQ) was used to gain participants' perception regarding the necessity of and concerns about medications. 27 Individual question responses were used to establish participant harm, overuse, life-saving, and burden belief. Composite scoring for the BMQ was not used as the survey did not include the full BMQ questionnaire, which restricted scoring to responses to individual items. Participants rated agreement with included statements based on a 7-point Likert scale. Based upon the Concerns-Necessity Framework, necessity beliefs have previously been shown to be positively related to medication adherence, while concerns, overuse beliefs, and harm beliefs have been shown to be negatively related. 28 Additionally, respondents were also asked to rate their level of agreement using the same Likert scale to the statement, "Purchasing medications causes me financial hardship." This served as the marker for financial hardship, with higher numerical values being associated with greater levels of agreement that purchasing medications cause financial hardship. Participants were also asked to rate their overall health on a 4-point scale, ranging from excellent to poor.
Analysis
Participant demographics and characteristics, medication adherence, and population density of ZIP code were reported using descriptive statistics. Multivariate regression analyses were used to assess associations between medication adherence (the dependent variable) and education level, household income, medications causing financial hardship, age, self-rated health score, distance to the nearest pharmacy, use of mail order pharmacies, use of the drive-through at their pharmacy, medication burden belief, medication life-saving belief, medication overuse belief, total number of prescription medications taken daily, and medication harm belief (independent variables). All independent variables were added to the models at the same time. Education level, household income, use of mail order pharmacies, and use of a drivethrough at the pharmacy were treated as categorical variables, with lowest level of education and lowest income level serving as the reference level. As it was hypothesized that the importance of these factors differed between rural, suburban, and urban participants, separate models were constructed for each cohort. Additionally, these cohorts were further deconstructed by age groups because of the significant difference in age groupings between cohorts, and regression models were constructed for each subset.
Software
All participants' records were stored in a relational database using the open-source database software MySQL (v. 5.7.11, Oracle, Redwood Shores, California). All analytics were performed using the open-source statistical computing software R (v 3.2.3, R Foundation, Vienna, Austria).
Results
Of the 26,173 participants, 16,677 reported taking between 1 and 30 prescription medications. Of those taking prescription medications, a total of 15,933 participants met the additional inclusion criteria. Based on the 2010 RUCA designations, a total of 1,735 participants were rural dwellers, 5,302 were suburban dwellers, and 8,896 urban dwellers.
The demographic makeup of the 3 levels of population density varied significantly, with individuals under the age of 41 making up over 44% of the population for urban centers while this same age group accounted for only 35% of the population in rural areas. Conversely, individuals over the age of 54 accounted for a larger proportion of rural participants, with 44% of them living in rural areas and 37% in urban areas. The difference in the age distribution results in rural areas having an average age of 49.1 years and urban areas having an average age of 46.3 years (P < .005; Table 1 ).
Income distribution was similarly unevenly distributed between the 3 subgroups. The percentage of individuals with a household income of less than $40,000 per year was greatest among rural participants, compared to suburban and urban areas (54.9%, 46.2%, and 39.7%, respectively). Differences also existed by educational status, sex, and ethnicity. Table 1 provides further demographic information about the participants contained within each group. The overall mean adherence score based on the MMAS-8 was 5.6 (SD = 2.0) for all participants. The mean adherence score was compared for rural, suburban, and urban participants, as was the proportion of participants meeting certain adherence criteria. There was no significant difference between each of the groups based on mean adherence scores (Table 2) . Rurality groups had roughly equivalent proportions of individuals classified as low adherence (MMAS-8 < 6; rural 49.5%, suburban 50.3%, and urban 50.7%), medium adherence (MMAS-8 ࣙ 6 and < 8; rural 27.5%, suburban 28.2%, and urban 28.3%) and high adherence (MMAS-8 = 8; rural 23.1%, suburban 21.6%, and urban 21.0%; Table 2 ).
Based on subset analyses of each of the designations according to population density, similar adherence scores were also shown between rural, suburban, and urban participants when categorized by other demographic factors. For instance, there were no statistically significant differences in medication adherence scores between rural, urban, and suburban participants when comparing the same age groups, income groups, education level, sex, and ethnicity (Table 3) .
A multivariable linear regression was constructed for all participants, as well as separately for rural participants and urban participants ( Table 4 ). The results of the overall and separated rural versus urban regression models showed similarities. However, some factors included in the model had significance only in urban participants and not rural participants, including distance to pharmacy (B = −0.01, P < .001), use of mail order pharmacies (B = −0.14, P = .002), and perceptions of medication-related factors.
To better understand potential differences among various age groups of rural and urban dwellers, a series of multivariable linear regression subset analyses were conducted. The results for rural versus urban cohorts based on age groupings (aged 18-41, 42-64, and 65+) can be found in Table 5 . According to the regression analysis, factors that are significantly associated with adherence varied dependent on population density and age groupings. Comparing urban and rural while holding age group constant revealed differences and similarities between rural and urban participants. For instance, adherence of rural and urban participants aged 65 and older were both impacted by financial hardship (P = .004, P < .001, respectively) and perception of medication as a burden (P = .010, P < .001, respectively); whereas only the adherence for urban individuals over 65 years of age was impacted by the use of drive-through pharmacies (P < .001), and their overall health ranking (P < .001).
Discussion
Among all the different demographic factors, age had the largest impact on adherence with those aged 18-29 reporting an average mean score of 4.85, while those aged 65 and over reported an average adherence score of 6.69, with a higher score equating to better adherence. Additionally, increased income, increased education level, male sex, and white race/ethnicity are all associated with increased adherence for all participants in this study. Initial interpretation of the data suggests that medication use and adherence is the same between rural, suburban, and urban individuals. This is, however, complicated by the fact that participant demographics and general characteristics are different between each of these groups. Previous research has established positive relationships with age and female sex with increased adherence to prescription medications. With the rural group of participants being significantly older and having a larger proportion of females than suburban and urban participants, one would assume that the rural group would have increased adherence rates. 29, 30 This is, however, counterbalanced by the fact the rural participants reported lower income levels and an increased distance to the nearest pharmacy, which are associated with lower levels of medication adherence.
Based on separate regression analyses for rural and urban participants, the demographic and belief factors impacting adherence between rural and urban participants vary (Tables 4 and 5 ). Adherence for rural participants over the age of 65 was negatively influenced by financial hardship of medications, whereas adherence for these individuals was positively impacted by perceptions of medication burden. Alternatively, adherence for urban participants over the age of 65 was negatively impacted by financial hardship, use of drive-through pharmacies, and overall health ratings, but adherence was positively affected by perceptions of medication burden.
Additionally, differences between factors that impact adherence among different age groups of rural participants were shown. For instance, adherence for individuals aged 18-41 and 42-65 was impacted by overall health score and use of drive-through pharmacies, while these 2 variables were not related to adherence of rural participants older than 65. The differential relationship between self-rated health status and adherence based on age of rural participants may suggest that younger rural participants with worse perceived health place increased importance on adhering to their medication.
Financial hardship was shown to negatively impact adherence across all age groups, regardless of being identified as urban or rural dwellers. Although this factor impacts medication for participants from all population densities, it was hypothesized that this would be of greater importance for rural participants, considering the higher levels of poverty and lower median household incomes reported in rural areas compared to urban areas. 31 This was, however, not supported by the results of this study, which suggested financial hardship was equally impactful for urban and rural dwellers. It is important to note that the negative correlation between financial hardship and adherence should be interpreted as higher levels of agreement that medications cause financial hardship is associated with lower MMAS-8 scores, which equates to worse adherence. Similarly, the use of a drive-through at the pharmacy was associated with worse adherence, hence, the negative beta coefficient reported in Table 4 . However, this study is not able to determine if these relationships are causative in nature. Additional research is needed to evaluate this further. 
Limitations
This study had a number of limitations that the authors wish to describe. First, data collection was conducted electronically, which requires individuals to have internet and computer access to enroll in the study. This may have been a limiting factor for both older populations and those living in more rural areas. Second, the use of a self-reported adherence scale, such as the MMAS-8, does limit the researchers' ability to verify the accuracy of the levels of adherence reported. The MMAS-8 has been widely used and validated, but self-reporting of adherence without incorporation of additional metrics has potential limitations. Additionally, the data collected only allowed researchers to report correlations between individual factors and adherence. The nature of the data collected does not allow researchers to determine if each factor is causative in nature, which would require additional data collection. Last, it is important to note that each subgroup did not contain the same number of responses.
Conclusion
The percentage of participants falling into the low adherence category, approximately 50%, is similar between rural, urban, and suburban dwellers. This finding is similar to previous research in medication adherence and is generally concerning. When comparing factors impacting adherence between rural and urban individuals and those of different age clusters, distinct overall factors influencing adherence were identified for each group. However, many adherence interventions to date target a single variable identified as a potential factor that impacts adherence. Based on the results of this study, adherence interventions should be further individualized, particularly when considering population density and age. Development of screening tools and targeted adherence approaches may increase the success of such adherence interventions. One factor that should be evaluated among all participants is the impact of financial hardship on medication use, as all participant groups had negative associations between financial hardship and adherence. Additionally, the use of the drive-through at local pharmacies should be further reviewed, as the reported use of such services was negatively associated with adherence across all participant groups.
